메뉴 건너뛰기




Volumn 43, Issue 3, 2006, Pages 117-121

Neoadjuvant chemotherapy followed by surgical cytoreduction in advanced epithelial ovarian cancer

Author keywords

Advanced ovarian cancer; Neoadjuvant chemotherapy; Surgical cytoreduction

Indexed keywords


EID: 33750705637     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-509X.27933     Document Type: Article
Times cited : (11)

References (35)
  • 2
    • 6044262405 scopus 로고    scopus 로고
    • Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India
    • Yeole BB, Kumar AV, Kurkure A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev 2004;5:308-15.
    • (2004) Asian Pac J Cancer Prev , vol.5 , pp. 308-315
    • Yeole, B.B.1    Kumar, A.V.2    Kurkure, A.3    Sunny, L.4
  • 3
    • 11844278537 scopus 로고    scopus 로고
    • Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000
    • Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer 2005;113:977-90.
    • (2005) Int J Cancer , vol.113 , pp. 977-990
    • Bray, F.1    Loos, A.H.2    Tognazzo, S.3    La Vecchia, C.4
  • 4
    • 18144395073 scopus 로고    scopus 로고
    • Ovarian cancer incidence in the United States, 1992-1999
    • Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005;97:519-23.
    • (2005) Gynecol Oncol , vol.97 , pp. 519-523
    • Quirk, J.T.1    Natarajan, N.2
  • 5
    • 0000958776 scopus 로고    scopus 로고
    • Ovarian cancer, fallopian tube carcinoma and peritoneal carcinoma
    • DeVita VT Jr, Hellman S, Rosenberg SA, Editors. Williams and Wilkins: Lippincott
    • th ed. Williams and Wilkins: Lippincott; 2001. p. 1597-632.
    • (2001) th Ed. , pp. 1597-1632
    • Ozols, R.F.1    Schwartz, P.E.2    Eifel, P.J.3
  • 6
    • 0033936074 scopus 로고    scopus 로고
    • Ovarian cancer: Epidemiology, biology and prognostic factors
    • Holschneider CH, Berek JS. Ovarian cancer: Epidemiology, biology and prognostic factors. Semin Surg Oncol 2000;19:3-10.
    • (2000) Semin Surg Oncol , vol.19 , pp. 3-10
    • Holschneider, C.H.1    Berek, J.S.2
  • 8
    • 0027525996 scopus 로고
    • Surgical staging and cytoreductive surgery of epithelial ovarian cancer
    • Hoskins WJ. Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer 1993;71:1534-40.
    • (1993) Cancer , vol.71 , pp. 1534-1540
    • Hoskins, W.J.1
  • 9
    • 0028237380 scopus 로고
    • The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
    • Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-80.
    • (1994) Am J Obstet Gynecol , vol.170 , pp. 974-980
    • Hoskins, W.J.1    McGuire, W.P.2    Brady, M.F.3    Homesley, H.D.4    Creasman, W.T.5    Berman, M.6
  • 10
    • 0036498788 scopus 로고    scopus 로고
    • Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    • Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FL. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002;20:1248-59.
    • (2002) J Clin Oncol , vol.20 , pp. 1248-1259
    • Bristow, R.E.1    Tomacruz, R.S.2    Armstrong, D.K.3    Trimble, E.L.4    Montz, F.L.5
  • 12
    • 0025125086 scopus 로고
    • The potential of primary cytoreductive surgery in patients with FIGO stages III and IV ovarian carcinoma
    • Fioretti P, Gadducci A, Del Bravo B, Prato B. The potential of primary cytoreductive surgery in patients with FIGO stages III and IV ovarian carcinoma. Eur J Gynaecol Oncol 1990;11:175-9.
    • (1990) Eur J Gynaecol Oncol , vol.11 , pp. 175-179
    • Fioretti, P.1    Gadducci, A.2    Del Bravo, B.3    Prato, B.4
  • 13
    • 0038162281 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
    • Mazzeo F, Berliere M, Kerger J, Squiflett J, Duck L, D'Hondt V, et al. Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecol Oncol 2003;90:163-9.
    • (2003) Gynecol Oncol , vol.90 , pp. 163-169
    • Mazzeo, F.1    Berliere, M.2    Kerger, J.3    Squiflett, J.4    Duck, L.5    D'Hondt, V.6
  • 14
    • 0028952438 scopus 로고
    • The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the European organization for research and treatment of cancer
    • van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favelli G, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative group of the European organization for research and treatment of cancer. N Engl J Med 1995;332:629-34.
    • (1995) N Engl J Med , vol.332 , pp. 629-634
    • Van Der Burg, M.E.1    Van Lent, M.2    Buyse, M.3    Kobierska, A.4    Colombo, N.5    Favelli, G.6
  • 15
    • 18344391714 scopus 로고    scopus 로고
    • The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer
    • Pectasides D, Farmakis D, Koumarianou A. The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer. Oncology 2005;68:64-70.
    • (2005) Oncology , vol.68 , pp. 64-70
    • Pectasides, D.1    Farmakis, D.2    Koumarianou, A.3
  • 16
    • 0032422162 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
    • Vergote I, De Wever I, Tjalma W, Van Grambaren M, Decloidt J, van Dam P. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients. Gynecol Oncol 1998;71:431-6.
    • (1998) Gynecol Oncol , vol.71 , pp. 431-436
    • Vergote, I.1    De Wever, I.2    Tjalma, W.3    Van Grambaren, M.4    Decloidt, J.5    Van Dam, P.6
  • 17
    • 3042823262 scopus 로고    scopus 로고
    • The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma
    • Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 2004;101:346-52.
    • (2004) Cancer , vol.101 , pp. 346-352
    • Dowdy, S.C.1    Mullany, S.A.2    Brandt, K.R.3    Huppert, B.J.4    Cliby, W.A.5
  • 20
    • 0027394686 scopus 로고
    • Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma
    • Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993;11:166-72.
    • (1993) J Clin Oncol , vol.11 , pp. 166-172
    • Nelson, B.E.1    Rosenfield, A.T.2    Schwartz, P.E.3
  • 21
    • 12344325535 scopus 로고    scopus 로고
    • Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer
    • Qayyum A, Coakley FV, Westphalen AC, Hricak H, Okuno WT, Powell B. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 2005;96:301-6.
    • (2005) Gynecol Oncol , vol.96 , pp. 301-306
    • Qayyum, A.1    Coakley, F.V.2    Westphalen, A.C.3    Hricak, H.4    Okuno, W.T.5    Powell, B.6
  • 22
    • 0242608855 scopus 로고    scopus 로고
    • Ovaries and fallopian tubes
    • nd ed.: Churchill Livingston
    • nd ed. Clinical Oncology: Churchill Livingston; 2000. p. 2020-35.
    • (2000) Clinical Oncology , pp. 2020-2035
    • Thigpen, J.T.1
  • 25
    • 0024506224 scopus 로고
    • Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A gynecologic oncology group study
    • Omura GA, Bundy BN, Berek JS, Curry S, Delgado G, Mortel R. Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A gynecologic oncology group study. J Clin Oncol 1989;7:457-65.
    • (1989) J Clin Oncol , vol.7 , pp. 457-465
    • Omura, G.A.1    Bundy, B.N.2    Berek, J.S.3    Curry, S.4    Delgado, G.5    Mortel, R.6
  • 26
    • 0030054309 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    • McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
    • (1996) N Engl J Med , vol.334 , pp. 1-6
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3    Kucera, P.R.4    Partridge, E.E.5    Look, K.Y.6
  • 27
    • 0026589291 scopus 로고
    • A multicenter phase II study of carboplatin in advanced ovarian carcinoma: Final report
    • Kjorstad K, Harris A, Bertelsen K, Slevin M, Shultz H, Hellman K, et al. A multicenter phase II study of carboplatin in advanced ovarian carcinoma: Final report. Ann Oncol 1992;3:217-22.
    • (1992) Ann Oncol , vol.3 , pp. 217-222
    • Kjorstad, K.1    Harris, A.2    Bertelsen, K.3    Slevin, M.4    Shultz, H.5    Hellman, K.6
  • 28
    • 0027055485 scopus 로고
    • Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma
    • Einzig AI, Wiernik PH, Sasloff J, Runowicz CD, Goldberg GL. Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol 1992;10:1748-53.
    • (1992) J Clin Oncol , vol.10 , pp. 1748-1753
    • Einzig, A.I.1    Wiernik, P.H.2    Sasloff, J.3    Runowicz, C.D.4    Goldberg, G.L.5
  • 29
    • 0642333855 scopus 로고    scopus 로고
    • Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer
    • Morice P, Dubernard G, Rey A, Atallah D, Pautier P, Pomel C, et al. Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg 2003;197:955-63.
    • (2003) J Am Coll Surg , vol.197 , pp. 955-963
    • Morice, P.1    Dubernard, G.2    Rey, A.3    Atallah, D.4    Pautier, P.5    Pomel, C.6
  • 30
    • 0028283281 scopus 로고
    • Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer
    • Guidozzi F, Ball JH. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 1994;53:326-30.
    • (1994) Gynecol Oncol , vol.53 , pp. 326-330
    • Guidozzi, F.1    Ball, J.H.2
  • 32
    • 1942462676 scopus 로고    scopus 로고
    • The role of interval debulking surgery in ovarian cancer
    • Gynecological Cancer Group of the EORTC
    • van der Burg ME, Vergote I; Gynecological Cancer Group of the EORTC. The role of interval debulking surgery in ovarian cancer. Curr Oncol Rep 2003;5:473-81.
    • (2003) Curr Oncol Rep , vol.5 , pp. 473-481
    • Van Der Burg, M.E.1    Vergote, I.2
  • 33
    • 0035889879 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma
    • Kuhn W, Rutke S, Spathe K, Schmalfeldt B, Florack G, von Hundelshausen B, et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer 2001;92:2585-91.
    • (2001) Cancer , vol.92 , pp. 2585-2591
    • Kuhn, W.1    Rutke, S.2    Spathe, K.3    Schmalfeldt, B.4    Florack, G.5    Von Hundelshausen, B.6
  • 34
    • 15744406047 scopus 로고    scopus 로고
    • The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma
    • Eitan R, Levine DA, Abu-Rustum N, Sonoda Y, Huh JN, Franklin CC, et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer 2005;103:1397-401.
    • (2005) Cancer , vol.103 , pp. 1397-1401
    • Eitan, R.1    Levine, D.A.2    Abu-Rustum, N.3    Sonoda, Y.4    Huh, J.N.5    Franklin, C.C.6
  • 35
    • 0026648619 scopus 로고
    • The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma
    • Goodman HM, Harlow BL, Sheets EE, Mooto MG, Brooks S, Stellar M, et al. The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma. Gynecol Oncol 1992;46:367-71.
    • (1992) Gynecol Oncol , vol.46 , pp. 367-371
    • Goodman, H.M.1    Harlow, B.L.2    Sheets, E.E.3    Mooto, M.G.4    Brooks, S.5    Stellar, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.